Dose escalation of a curcuminoid formulation
暂无分享,去创建一个
Daniel Normolle | Dean E Brenner | Mack T Ruffin | C. Rock | J. Crowell | D. Normolle | M. Ruffin | C. Lao | D. Brenner | Cheryl L Rock | Dennis D. Heath | Christopher D Lao | Dennis D Heath | Martha E Boggs | Sandra I Murray | Joanne M Bailey | James Crowell | J. Bailey | D. Heath | Martha E. Boggs | Sandra I. Murray
[1] Jen-kun Lin,et al. Biotransformation of curcumin through reduction and glucuronidation in mice. , 1999, Drug metabolism and disposition: the biological fate of chemicals.
[2] Sanjiv J. Shah,et al. Evaluation of anti-inflammatory property of curcumin (diferuloyl methane) in patients with postoperative inflammation. , 1986, International journal of clinical pharmacology, therapy, and toxicology.
[3] J. Plummer,et al. The metabolism and excretion of curcumin (1,7-bis-(4-hydroxy-3-methoxyphenyl)-1,6-heptadiene-3,5-dione) in the rat. , 1978, Xenobiotica; the fate of foreign compounds in biological systems.
[4] M. Majeed,et al. Influence of piperine on the pharmacokinetics of curcumin in animals and human volunteers. , 1998, Planta medica.
[5] R. Srimal,et al. Pharmacology of diferuloyl methane (curcumin), a non‐steroidal anti‐inflammatory agent * , 1973, The Journal of pharmacy and pharmacology.
[6] V. Ravindranath,et al. Metabolism of curcumin--studies with [3H]curcumin. , 1981, Toxicology.
[7] L. Howells,et al. Characterization of metabolites of the chemopreventive agent curcumin in human and rat hepatocytes and in the rat in vivo, and evaluation of their ability to inhibit phorbol ester-induced prostaglandin E2 production. , 2001, Cancer research.
[8] G. Blennow,et al. A study on the fate of curcumin in the rat. , 2009, Acta pharmacologica et toxicologica.
[9] N. Ghatak,et al. Anti-inflammatory and irritant activities of curcumin analogues in rats , 1982, Agents and Actions.
[10] C. Rao,et al. Chemoprevention of colon carcinogenesis by dietary curcumin, a naturally occurring plant phenolic compound. , 1995, Cancer research.
[11] R. Smart,et al. Inhibitory effect of curcumin, chlorogenic acid, caffeic acid, and ferulic acid on tumor promotion in mouse skin by 12-O-tetradecanoylphorbol-13-acetate. , 1988, Cancer research.
[12] C. Rock,et al. Curcumin in plasma and urine: quantitation by high-performance liquid chromatography. , 2003, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.
[13] R. Kuttan,et al. Effect of oral curcumin administration on serum peroxides and cholesterol levels in human volunteers. , 1992, Indian journal of physiology and pharmacology.
[14] B. Aggarwal,et al. Anticancer potential of curcumin: preclinical and clinical studies. , 2003, Anticancer research.
[15] M. Pirmohamed,et al. Pharmacodynamic and pharmacokinetic study of oral Curcuma extract in patients with colorectal cancer. , 2001, Clinical Cancer Research.
[16] V. Ravindranath,et al. Absorption and tissue distribution of curcumin in rats. , 1980, Toxicology.
[17] S. Jee,et al. Phase I clinical trial of curcumin, a chemopreventive agent, in patients with high-risk or pre-malignant lesions. , 2001, Anticancer research.
[18] Clinical development plan: Curcumin , 2002 .
[19] V. Ravindranath,et al. In vitro studies on the intestinal absorption of curcumin in rats. , 1981, Toxicology.
[20] Donald J L Jones,et al. Metabolism of the cancer chemopreventive agent curcumin in human and rat intestine. , 2002, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[21] Y. Lou,et al. Inhibitory effects of dietary curcumin on forestomach, duodenal, and colon carcinogenesis in mice. , 1994, Cancer research.
[22] S. Deodhar,et al. Preliminary study on antirheumatic activity of curcumin (diferuloyl methane). , 1980, The Indian journal of medical research.